Skip to main content
Clinical Trials/NCT03284905
NCT03284905CompletedNot Applicable

Probiotic Intervention for Acute Stress

Probi AB2 sites in 1 country70 target enrollmentStarted: October 2, 2017Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Probi AB
Enrollment
70
Locations
2
Primary Endpoint
Reduction of the cortisol level during acute stress

Study Overview

Brief Summary

Efficacy of probiotics on acute stress

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Prevention
Masking
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

Eligibility Criteria

Ages
19 Years to 35 Years (Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • 19-35 years
  • SMBQ-score ≥3.75
  • Understand Swedish in spoken and written terms
  • Willing and able to give written informed consent for participating in the study
  • Intake of probiotics within two weeks prior to the start of the study

Exclusion Criteria

  • Antibiotic treatment in the last three months
  • Known disease (diabetes, pulmonary or cardiovascular disease, celiac disease, thyroid problems, gastrointestinal disease) or mental illness
  • Use of psychotropic drugs, beta blockers, asthma or rheumatoid arthritis drugs, steroid drugs or local steroid treatment

Arms & Interventions

Probiotics

Active Comparator

Intervention: Probiotic supplement (Dietary Supplement)

Placebo

Placebo Comparator

Intervention: Placebo supplement (Dietary Supplement)

Outcomes

Primary Outcomes

Reduction of the cortisol level during acute stress

Time Frame: 2.5 hours

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Probi AB
Sponsor Class
Industry
Responsible Party
Sponsor

Study Sites (2)

Loading locations...

Similar Trials

Probiotic Intervention for Acute Stress | Clinical Trial